Author:
Vanjak D.,Muller-Serieys C.,Picard B.,Bergogne-Berezin E.,Lambert-Zechovsky N.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference20 articles.
1. Medeiros AA: Beta-lactamases. British Medical Bulletin 1984, 40: 18–27.
2. Jacobs MR, Aronoff SC, Johenning S, Shlaes DM, Yamabe S: Comparative activities of the β-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined β-lactamase producing aerobic gramnegative bacilli. Antimicrobial Agents and Chemotherapy 1986, 29: 980–985.
3. Kuck NV, Jacobus PJ, Petersen PJ, Weiss WJ, Testa RT: Comparative in vitro and in vivo activities of piperacillin combined with the β-lactamase inhibitors tazobactam, clavulanic acid and sulbactam. Antimicrobial Agents and Chemotherapy 1989, 33: 1964–1969.
4. Hamilton-Miller JMT: Beta-lactamases and their clinical significance. Journal of Antimicrobial Chemotherapy 1982, 9, Supplement B: 11–19.
5. Acar J, Bergogne-Berezin E, Brognard JM, Chabbert Y, Cluzel R, Courvalin P, Dabernat H, Drugeon H, Dubreuil L, Duval J, Flandrois JP, Goldstein F, Meyran M, Morel CI, Philippon A, Sirot J, Thabaut A: Communiqué 1993 du Comité de l'Antibiogramme de la Société Française de Microbiologie. Pathologie Biologie 1993, 41: 741–748.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献